New 'Smart Bomb' drug tested for Tough-to-Treat advanced cancers

NCT ID NCT03964727

Ongoing Disease control Sponsor: Gilead Sciences Source: ClinicalTrials.gov ↗

Summary

This study tested an experimental drug called sacituzumab govitecan in people with advanced solid tumors that had spread and stopped responding to standard treatments. The drug is designed to deliver chemotherapy directly to cancer cells. Researchers measured how well the tumors shrank and how long patients lived without their cancer getting worse.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Alaska Oncology & Hematology, LLC

Anchorage, Alaska, 99508, United States
Arizona Oncology Associates PC-HAL

Goodyear, Arizona, 85395, United States
Blacktown Hospital

Westmead, New South Wales, 2145, Australia
Blue Ridge Cancer Care - Wytheville

Blacksburg, Virginia, 24060, United States
Calvary Mater Newcastle Hospital

Waratah, New South Wales, 2298, Australia
Centre George Francois Leclerc

Dijon, 21000, France
Chang Gung Medical Foundation, Linkou Chang Gung Memorial Hospital

Taoyuan, 33305, Taiwan
Changhua Christian Hospital

Changhua, Taiwan
Chi Mei Medical Center

Tainan, Taiwan
Christus Highland Cancer Treatment Center

Shreveport, Louisiana, 71105, United States
Cliniques Universitaires UCL Saint-Luc

Brussels, 1200, Belgium
Comprehensive Cancer of Nevada

Las Vegas, Nevada, 89052, United States
Cross Cancer Institute

Edmonton, T6G 1Z2, Canada
David C. Pratt Center

St Louis, Missouri, 63141, United States
Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital

Shatin, Hong Kong
Grand Hopital de Charleroi asbl (GHdC)

Charleroi, 6000, Belgium
Highlands Oncology Group

Springdale, Arkansas, 72762, United States
Hong Kong Integrated Oncology Centre

Central, Hong Kong
Hong Kong Sanatorium & Hospital

Happy Valley, Hong Kong
Hong Kong United Oncology Center

Kowloon, Hong Kong
Hospital Clínico Universitario de Valencia

Valencia, 46010, Spain
Hospital Universitari Vall d'Hebron

Barcelona, 8035, Spain
Hospital Universitario 12 de Octubre

Madrid, 28041, Spain
Hospital de la Santa Creu i Sant Pau

Barcelona, 08041, Spain
Institut Bergonie

Bordeaux, 33000, France
Institut Català d'Oncologia

Barcelona, 08908, Spain
Institut Claudius Régaud - IUCT Oncopole

Toulouse, 31059, France
Institut Gustave Roussy

Villejuif, 94805, France
Jewish General Hospital

Montreal, H3T 1E2, Canada
Karmanos Cancer Institute

Detroit, Michigan, 48201, United States
London Health Sciences Centre- Victoria Hospital

London, N6A 5W9, Canada
Lyell McEwin Hospital

Elizabeth Vale, South Australia, 5112, Australia
Macquarie University

North Ryde, New South Wales, 2109, Australia
Mater Cancer Centre, Mater Misericordiae Limited

South Brisbane, Queensland, 4101, Australia
Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States
Monash Medical Centre, Monash Health

Clayton, Victoria, 3168, Australia
Montefiore Medical Center

The Bronx, New York, 10467, United States
National Cheng Kung University Hospital

Tainan, Taiwan
New York Oncology Hematology - Albany Medical Center

Albany, New York, 12208, United States
North Mississippi Medical Center - Hematology and Oncology - Tupelo

Tupelo, Mississippi, 38801, United States
Parkview Research Center

Fort Wayne, Indiana, 46845, United States
PathGroup Labs, LLC

Fort Wayne, Indiana, 46804, United States
Pindara Private Hospital

Benowa, Queensland, 4217, Australia
Providence Regional Cancer Partnership

Everett, Washington, 98201, United States
Queen Mary Hospital

Hong Kong, Hong Kong
SIU School of Medicine, Simmons Cancer Institute at SIU

Springfield, Illinois, 62702, United States
Smilow Cancer Hospital at Yale

New Haven, Connecticut, 06520, United States
Southern Highlands Cancer Center

Bowral, New South Wales, 2576, Australia
TRIO-US Central Administration

Whittier, California, 90602, United States
Taipei TzuChi Hospital

New Taipei City, Taiwan
Tennessee Oncology, PLLC

Nashville, Tennessee, 37203, United States
Texas Oncology - Tyler

Tyler, Texas, 75702, United States
The Andrew Love Cancer Centre, Geelong Hospital

Geelong, Victoria, 3220, Australia
The Ottawa Hospital

Ottawa, K1H 8L6, Canada
The University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States
UCLA Hematology/Oncology

Los Angeles, California, 90095, United States
USOR - Arizona Oncology - Glendale - Saguaro Cancer Center

Glendale, Arizona, 85308, United States
University Hospitals Cleveland Medical Center

Cleveland, Ohio, 44106, United States
University of Colorado Hospital - Anschutz Cancer Pavilion

Aurora, Colorado, 80045, United States
University of Kentucky Medical Center

Lexington, Kentucky, 40536, United States
University of Michigan Rogel Cancer Center

Ann Arbor, Michigan, 48109, United States
Virginia Cancer Specialists, PC

Fairfax, Virginia, 22031, United States
Washington University School of Medicine - Siteman Cancer Center

St Louis, Missouri, 63110, United States
Weill Cornell Medicine - Upper East Side

New York, New York, 10065, United States
Willamette Valley Cancer Institute and Research Center - Eugene

Eugene, Oregon, 97401, United States

Conditions

Explore the condition pages connected to this study.

METASTATIC SOLID TUMOR